menu
    • menu

    Company profile for Octapharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are the largest privately owned and independent plasma fractionator in the world. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care. Octapharma is one of the largest hum...
    We are the largest privately owned and independent plasma fractionator in the world. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care. Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OctapharmaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Seidenstrasse 2 8853 Lachen
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.octapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/octapharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OctapharmaGroup

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
    Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis

    11 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241211594907/en

    BUSINESSWIRE
    11 Dec 2024
    Share Share
    Octapharma USA Gets FDA EUA For octaplasLG Powder For Military Use
    Octapharma USA Gets FDA EUA For octaplasLG Powder For Military Use

    20 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/octapharma-usa-receives-fda-emergency-use-authorization-for-octaplaslg-powder-allows-us-military-medical-providers-emergent-use-in-treatment-of-hemorrhage-or-coagulopathy-302225567.html

    PR NEWSWIRE
    20 Aug 2024
    Share Share
    FDA Approves New Indication For Fibryga®
    FDA Approves New Indication For Fibryga®

    01 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-additional-indication-for-fibryga-for-fibrinogen-supplementation-in-bleeding-patients-with-acquired-fibrinogen-deficiency-potentially-ushering-in-a-new-standard-of-care-302213110.html

    PR NEWSWIRE
    01 Aug 2024
    Share Share
    Octapharma Showcases Rare Bleeding Disorders Commitment At ISTH 2024
    Octapharma Showcases Rare Bleeding Disorders Commitment At ISTH 2024

    10 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/octapharmas-continuing-dedication-to-improving-the-lives-of-people-with-rare-bleeding-disorders-to-be-showcased-at-isth-2024-302168275.html

    PR NEWSWIRE
    10 Jun 2024
    Share Share
    Octapharma USA Appoints Kelly Hearn VP Commercial Marketing
    Octapharma USA Appoints Kelly Hearn VP Commercial Marketing

    20 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/octapharma-usa-appoints-biopharma-industry-veteran-kelly-hearn-vice-president-of-commercial-marketing--development-302149326.html

    PR NEWSWIRE
    20 May 2024
    Share Share
    Octapharma's wilate® Gets FDA Orphan Exclusivity for VWD Prophylaxis
    Octapharma's wilate® Gets FDA Orphan Exclusivity for VWD Prophylaxis

    29 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/octapharma-usa-fda-grants-orphan-drug-exclusivity-to-wilate-the-first-vwf-concentrate-for-prophylaxis-in-all-types-of-vwd-302128969.html

    PR NEWSWIRE
    29 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search